Form 4: NeueHealth Director Manuel Kadre Reports Stock Transactions
SEC Form 4 Filing
Director Manuel Kadre reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.
Summary
- On May 12, 2024, Director Manuel Kadre acquired 4,755 shares of NeueHealth, Inc. common stock and disposed of 19,320 shares.
- These transactions were related to the vesting of 4,755 restricted stock units, each representing a contingent right to receive one share of common stock.
- The restricted stock units vested on May 12, 2024, one year from the grant date.
- On May 13, 2024, Kadre acquired 10,500 restricted stock units which vest on May 13, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of key personnel.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Restricted stock units vested, acquisition of 4,755 shares, disposal of 19,320 shares. |
| 05/13/2024 | Acquisition of 10,500 restricted stock units. |
| 05/13/2025 | Vesting date for 10,500 restricted stock units acquired on May 13, 2024. |
| 05/14/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.